ࡱ> surwq`̗bjbjqPqP .::jS&bbbv000811v\2:3"636363u4u4u4[[[[[[[$A^h`T[b(<q4u4(<(<[6363;S\UUU(<@R63b63[U(<[UUV@"b,V632 0hKVX$i\0\$VaR.a,Vab,V\u4(6U'8<c9u4u4u4[[*ꨠƌ|t|h9mH sH h-$mH sH ht+mH sH hUkmH sH h(h 26mH sH hY<mH sH h 2mH sH h(h!mmH sH h(hI-mH sH h'mH sH hmH sH  *hhmH sH hbmH sH h(h 2mH sH h(hSDmH sH +>*********++ + +%+B+M+R+w+{+++,, , ,',3,;,<,=,?,G,N,P,Y,c,,Ժzrjbjrrrh{mH sH h _mH sH hUkmH sH h(h!m6mH sH h(h mH sH hmH sH h-$mH sH h9mH sH h-$6mH sH h!mmH sH h(h!mmH sH  h2h2h@=mH sH h2mH sH h26mH sH h 2mH sH h(h 2mH sH hXmH sH $,,,,,-------[.../K/L/M/N/d/~////////////Ź{p{dX *hXhXmH sH  *hXh!mmH sH h(hD"mH sH h(h#lmH sH h(h kmH sH hVmwmH sH h(h!m6mH sH h(hmH sH  *hN:mH sH  *h ah amH sH h!mmH sH h{mH sH h _mH sH hmH sH hkmH sH h(h!mmH sH hY<mH sH  /////////////////000$0'0@0T0W0000000000001!1"1#1%1'1,1ݿݿݷݬݤ݉ʿ}yuqumht+h{h _hVmwh9hbHh_h(hD"mH sH h6pYmH sH hSmH sH h,cmH sH h(h"mH sH h_mH sH h(hmH sH h(h kmH sH hkmH sH h(h!mmH sH h{mH sH h _mH sH hXmH sH *,1/1314151W1s1w11111111111112#2'2M2N2y2|22222233t3u333444444!4"4'4÷ãÓËww *hXh$amH sH h$amH sH h #mH sH h{mH sH hcd}mH sH hXmH sH  *hXhXmH sH  *hXhmH sH hmH sH h6pYhbHh~ht+hVmwh_hnhcd}hX *hXhX *hXh_.0N2u345555g<i?EFFFF"GGGGGGH[I/J & Fdhgd Tdhgdvdhgdu}dhgdbHdhgdt+dhgd('4(444/5C5F5J5R5U5V5c5d5p5q5u5{555566v6x6}6~66666666666677777 7!7*7+7@7輱蒎~zvzzzvzvz~vzvzvzhUJh,ch6hxheh,Lh2hmH sH h)uht+mH sH ht+B*mH phsH hht+mH sH hcd}mH sH hXmH sH  *hXhXmH sH  *hXht+mH sH ht+ht+mH sH h$amH sH hN:mH sH .@7a7c7d7e77777777777%8?8R8c8p888:3:=:::p;q;0<f<g<<<<<======i?j??????????@@&@8@=@Aϻϻ쪮쮦h~ImH sH h2mH sH h~h[h~I *hu}mH sH  *hhu}mH sH hTcmH sH hu}mH sH hTc *h" *hTchTch^0hj=h,ch6hxhUJ:AAAAB BBBEBFBbBlBmBsB{BBBBBBBBDDDDD]DaDlDnDoDpDqDĸЯĸĸyma *h@hxmH sH  *hu}h6mH sH  *h"mH sH  *h@mH sH  *hu}h|mH sH  *hu}hxmH sH  *hu}h(XmH sH  *hTcmH sH  *hu}hu}mH sH  *hu}h amH sH  *hu}h~mH sH  *hu}h~ImH sH hj=mH sH h~ImH sH ht+mH sH !qDrDEE$EIELEEEEEEEEEFFFFFFFFF!G"GGGGGɾɳߠwrjf_WP h ThxhxmH sH  hvhvhvhmhv\ hv\hvmH sH h|h6mH sH h|hxmH sH h|hemH sH h@mH sH h|hj=mH sH h|h<mH sH h|hmH sH h|h(XmH sH h|h QmH sH hu}mH sH  *h@h@mH sH  *h@h(XmH sH GGGGGGGGGGGGG HHZH[H\HgHmHHHHHHHHHH9I:IIIOIYI[I=J@JAJJJJJJJYKLFLGLLLLLLLLLLLȮȮϥ h!Vh!Vh!VmH sH h (hJ h!V]h!Vh (]h!Vh (5\h!Vh (\ h!Vh (h!V h (]h (h T]h (hx] h T\h Thx\ h Thxh T9/JJYKLLMZO(QVQUR STVWXXYZx[# & Fdhgdm & Fdhgd; & Fdhgd & Fdhgd23} & Fdhgdrf & Fdhgd!V & Fdhgd ( & Fdhgd TLLLLLLLMMMMDOFOZOQ Q"Q$Q(QVQURZR[R\R]R^RdReRfRhRmRnRoRpRrRsRuRwR{R|RRRRRRRRRRRRRRRRRRRRRRRRRRRRõçççççççççççççççh23}@OJQJmH sH h23}h23}5@OJQJh23}h23}@OJQJ h23}h23}@OJQJmHsHh6h ThJh!Vh!VmH sH  h!Vh!VBRRRRRSSSSS STTTVWWWWW"W#W+W1WWX XXYYYYrZsZZZZZ[[[w[x[[[[~v~tUh|h t\h|h-Z\ h|h-Zh|h-Z]h|hm]h|hm\h|hm5\ h|hmh h;h;h; hhhJh T h2;>h23}h23}@OJQJh23}@OJQJmH sH h23}h23}@OJQJ-Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study. Ann Oncol 2006; 17(Suppl. 4):iv31-2. FIGURE LEGENDS Figure 1 Title: Overall survival of NHL patients treated with ICE and IMVP. ICE full line; IMVP dashed line. Crosses indicate censored patients. Figure 2 Title: Event-free survival of NHL patients treated with ICE and IMVP. ICE - full line; IMVP - dashed line. Crosses indicate censored patients. TABLE 1 Patients' characteristics and outcomes TreatmentIMVPICEGender (M / F)13 / 1525 / 20Age (median / range) [years]47 / 15-68 44 / 17-64 NHL type (DLBCL / FL gr.III / PTCL / ALCL)14 / 8 / 0 / 6 21 / 1 / 9 / 14Stage (I / II / III / IV)1 / 5 / 4 / 111 / 14 / 10 / 20IPI (0-1 / 2 / 3 / 4-5)9 / 2 / 13 / 416 / 13 / 11 / 5Disease status (relapsed / refractory)14 / 1423 / 22Time from diagnosis to treatment (median / range) [months]12.5 / 3-60 12 / 2-83 No. of treatment lines (median / range)2 / 1-51 / 1-6B symptoms2224Toxicity gr. 3 & 4 hematologic infectious other 16 1212931Treatment related mortality11Response rate 47%39%2-year overall survival31%23%2-year event-free survival22%13% Abbreviations: DLBCL diffuse large B-cell lymphoma FL gr. III follicular lymphoma grade III PTCL peripheral T-cell lymphoma ALCL - anaplastic large cell lymphoma TABLE 2 Outcomes according to IPI and disease status prior to treatment IPI 0-2IPI 3-5RelapseRefractoryResponse rate50 %36 %57 %*31 %*2-year OS32 %*21 %*37 %20 %2-year EFS31 %17 %28 %*19 %* OS overall survival EFS event-free survival * - statistically significant difference (p<0.05) Figure 1  EMBED STATISTICA.Graph \s  Figure 2  EMBED STATISTICA.Graph \s      PAGE  PAGE 10 "#$%ɑ=bcdfmnȒՒ֒גؒޒ #$%&»ҷ hx\] h-\] h\] hd\] h4\]h _h4hZ1 h$p\]h/h$p\h/[h$p hZ1\]h|hZ1\]h|h S.\]h|hm\]h|hm\7#$45>ʑˑԑcde$dh$Ifa$gdx dh$IfgdZ1dhgd$pdhgdZ1ɒqeVV$dh$Ifa$gdx dh$IfgdZ1kd$$IflF, pB t06    44 laɒʒqeVV$dh$Ifa$gdx dh$IfgdZ1kd,$$IflF, pB t06    44 la ,<LqeeVV$dh$Ifa$gdx dh$IfgdZ1kd$$IflF, pB t06    44 la&,;EFUVWXZ[\]`abcguvٓړۓܓ!"#$*34ABKLMlmnov}~єҔؔٔޔߔ h=\] *h=h= hx\] h\] hd\] h-\] h\] h4\]NLMgvqeVV$dh$Ifa$gdx dh$IfgdZ1kd$$IflF, pB t06    44 laqeVV$dh$Ifa$gdx dh$IfgdZ1kd$$IflF, pB t06    44 laqeVV$dh$Ifa$gdx dh$IfgdZ1kd$$IflF, pB t06    44 la4ABLMqeVVVV$dh$Ifa$gdx dh$IfgdZ1kdu$$IflF, pB t06    44 laMNv~qeVV$dh$Ifa$gdx dh$IfgdZ1kd$$IflF, pB t06    44 laqeVV$dh$Ifa$gd- dh$IfgdZ1kd_$$IflF, pB t06    44 laÔɔʔ͔ΔqeVVGVVV$dh$Ifa$gd _$dh$Ifa$gd= dh$Ifgd!kd$$IflF, pB t06    44 laΔєҔӔ֔ؔZK$dh$Ifa$gd _kdI$$Ifl4F, `pB t06    44 lap $dh$Ifa$gd=ؔٔڔܔޔiZKK$dh$Ifa$gd=$dh$Ifa$gd _kd$$Ifl4F, pB t06    44 lap ޔߔi]NN$dh$Ifa$gd= dh$Ifgd=kd]$$Ifl4F, pB t06    44 lap /034789@STWX[\]^n )STٖږߖDEFGHQƾƶƶ֡hSh/[ h{h{ *h{h{H* *h{h{ *h{h= *h{h _h _h=hdhZ1hZ1h4\] h _\] *h=h= *h=h _>k_PP$dh$Ifa$gd= dh$Ifgd!kd$$IflF, pB t06    44 lap 048qeVV$dh$Ifa$gd= dh$Ifgd!kdi$$IflF, pB t06    44 la89TX\qeVV$dh$Ifa$gd= dh$Ifgd!kd$$IflF, pB t06    44 la\]^_n qid\\\\\\\dhgddgdZ1dhgdZ1kdS$$IflF, pB t06    44 la TUV^fny$dh$Ifa$gd{ dh$IfgdddhgddyzNB333$dh$Ifa$gd{ dh$Ifgddkd$$Iflr< 5  t0644 la?3 dh$Ifgddkd: $$Iflr< 5  t0644 la$dh$Ifa$gd{˖Ж?3 dh$Ifgddkd $$Iflr< 5  t0644 la$dh$Ifa$gd{ЖՖۖ?77dhgddkd $$Iflr< 5  t0644 la$dh$Ifa$gd{EFGHRSTtuvh]hgd" &`#$gddhgddQRTUpqrs×ėŗǗȗʗ˗̗ºh+h"0JmHnHuhTc hTc0JjhTc0JUh_5jh_5UjiZhSU%jDI hSCJUVaJnHtHj hSU%j`CI hSCJUVaJnHtHjhSUhSh/[&ŗƗǗȗɗʗ˗̗dhgddh]hgd" &`#$gd,1h. A!"#$% DyK  aurer@mef.hryK (mailto:aurer@mef.hrs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5B$$If!vh55p5B#v#vp#vB:Vl4 t6+55p5Bp $$If!vh55p5B#v#vp#vB:Vl4 t6+55p5Bp $$If!vh55p5B#v#vp#vB:Vl4 t6+55p5Bp $$If!vh55p5B#v#vp#vB:Vl t655p5Bp s$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bs$$If!vh55p5B#v#vp#vB:Vl t655p5Bp$$If!vh55555#v#v:Vl t655p$$If!vh55555#v#v:Vl t655p$$If!vh55555#v#v:Vl t655p$$If!vh55555#v#v:Vl t655ODd I h`b  c $A? ?3"`?"#O!:}>l~WAN b@=N!:}>l~WA()P<Nx uy/BH2I_F-R{UVɨFz ,,W^/EkhEWWVeXE/9f>&uuNs>̙ss<ߓlnnysw9rc37w yܲ|1G;ǟ ss'/eC:~+޷u慗X|݆ŗ[YE {.-twܿ/=Welf;w xݷKvۏٸ;kSog޴p;n,;fᵫꏟX~Kq]rq op|W,$o;ӻu oxu1^c~iƹd^mNo{,>S{P1^z/>}xx~ޗ;떝x~î޿uW} }{@Z|o?K#Xn;ܾa9߯;ޱ].kk3[sػ/-s\򥯨yn^Wz|W-O/>=>ss_߲9X8=ʯ}r9akf8.o_yFy=qv5<=kk%^%~}K.>/Yx~.BÞ }~#'/__/Q+eЏ?? :~&~>j}C߼rOO_ g _}~7?cb2*W[i(X)߀)?7 h!c'/__$<|c|ߎ uÿ߂?}O-6/ſ## 5C7   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghiklmnopqtyz{|}~Root Entry F/v Data jWordDocument.ObjectPool /_1226523488 E=O@  Ole ObjInfoContentsx%  !"#$& Oh+'Oh+'0   $ 0 <HPX`t| igor.aurer igor.aurer3@1@@B[?@yN =R N3{lF*8D~Na`AQ$=J ;_CGraph CGraphCommon#6l,94+" CGPresent2DCGPresentCommon2D [ES]0.#### [ES]0.####$`??F#F# CGPlot2DSeqCGPlotCommon2D  [ES]0.####0% [ES]0.#### o"JArial  d- x  CVariableStd CIDElement2007\2\12-13:19:50,984(0)X@-?@@@@@@@@@@@@@@@@"@"@&@*@,@0@3@4@=@A@E@G@ 2007\2\12-13:19:50,984(1)Group 1,@-II?>>??"6a#?g\h?i?>?8q9?}Y~?ØGy? ؟ ?OtO?VPi?ە]?}1T ? 3` >??"6a#?g\h?i?>?8q9?}Y~?ØGy? ؟ ?OtO?VPi?ە]?}1T ? 3` >??|'}'?qq??Y[?OO??88?ׂ-؂-?vwwwww?ll?X`?I?i?=??gIY??vc?|e +&?H?ru\?Ƣ?mЦm?Jn9,?'*V}?X`?i?ZJV? ?@?@Լ?@Լ?C6 6 C-?E@?@Լ?II?@Լ?II? CGPlot2DSimCGPlotCommon2DSim@  [ES]0.####0% [ES]0.####@ o"JArial@ d. x  2007\2\12-13:21:17,484(14)X@ @@@@ @"@0@1@2@6@E@ 2007\2\12-13:21:17,484(15)Y@ ll?i?i?i? ? ?@?@?@?@?@Լ? CAttribLine @E@@@Լ?ll?@Լ?ll?CGElConfCommon?@  [ES]0.####0% [ES]0.####@ o"JArial@  d/ x  2007\2\12-13:21:17,484(16)X@"?@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@*@<@ 2007\2\12-13:21:17,484(17)Y@"II?>>??|'}'?qq??Y[?OO??88?ׂ-؂-?vwwwww?ll?X`?I?i?=??gIY??vc?|e +&?H?ru\?Ƣ?mЦm?Jn9,?'*V}?X`?i?ZJV? ?@?@Լ?"?<@?@Լ?II?@Լ?II??    [ES]0.####0% [ES]0.####@ o"JArial@ d0 x  2007\2\12-13:21:17,484(18)X@??@@@@@@@@@@@@@@@@@@@@@.@8@9@A@ 2007\2\12-13:21:17,484(19)Group 2,@m۶m?m۶m۶?$I$I?۶m۶m?$I$I?I$I$??m۶m?m۶m۶?$I$I?۶m۶m?$I$I?I$I$??n۶m۶?ܶm۶m?I$I$?m۶m?%I$I?$I$I??۶m۶m?m۶m?I$I$?I$I$?I$I$?I$I$?F9 9 F?A@?I$I$?m۶m?I$I$?m۶m?@  [ES]0.####0% [ES]0.####@ o"JArial@ d1  x  2007\2\12-13:21:17,484(20)X@ @8@9@A@ 2007\2\12-13:21:17,484(21)Y@m۶m?I$I$?I$I$?I$I$? @A@ @I$I$?m۶m?I$I$?m۶m??@  [ES]0.####0% [ES]0.####@  o"JArial@  d2 x  2007\2\12-13:21:17,484(22)X@??@@@@@@@@@@@@@@@@@@@@@.@ 2007\2\12-13:21:17,484(23)Y@m۶m?m۶m۶?$I$I?۶m۶m?$I$I?I$I$??m۶m?m۶m۶?$I$I?۶m۶m?$I$I?I$I$??n۶m۶?ܶm۶m?I$I$?m۶m?%I$I?$I$I??۶m۶m?m۶m?I$I$??.@?I$I$?m۶m?I$I$?m۶m??CGAxis CGAxisCommon2I@@Months"JArial [ES]0.####0%o"JArialG  G  DG  G  f??I@@=?2??Cumulative Proportion Surviving"JArial [ES]0.####0%o"JArialG  G  DG  G  ‹????=?2??Q"JArial [ES]0.####0%o"JArialG  G  DG  G  CL????=?2I@@Q"JArial [ES]0.####0%o"JArialG  G  DG  G  ??I@@????3@ Q-@@hQ@pN STATISTICAOh+'0 ,DP\l    RITUXIMAB, BUT NOT A CHANGE FROM IMVP (IFOSFAMIDE, ETOPOSIDE, METHOTREXATE) TO ICE (IFOSFAMIDE, CARBOPLATINUM, ETOPOSIDE) IMPRDr. Igor Auerg//__"~~3~;怡r?~Be[? _v=cggo߃_&}u\ ??????&]G_W|C?p/____*~#~+", ?PS?#NOS| C߸aw?2\"O_mzq1>gxxxxuw[M\m 0h9W2mk>Ÿ?1~!r55r}v gq῏?'z/7s}3XdY%[Wÿߖo2#OŸ3n#g{_2?zOw.ζٛmlzϳퟭζݭζCK?u?? !2R{ǿ߄߆gۡ϶C}$@I3Woߍ w7?Pgۡ~ ~<~"~*~~*M? ggxl;w? ?//ï?_϶Cݟmş? J ;?u#??=~%AW;l;v#|?_;uw[xl;??~6rPgۡ7 g//__"~~3~;ޟm?GOO_ +^o7vP???~~~ =ogۻq} .#g+ޟm?<4K_oo]ggş!~.wvP?ssW?.϶Cݟmz>Ƨ O/~ ϶w]m 0h9W2mvPQg//__"~~3~;ޟm>;38ǟ?߇ ~=Cxl3g 3 K? ?5O2#OŸ3n#xRgͶ\{3y}l{^zl;ԿPgۡ> m//ߊ(y[Mmxl;G???5f>s?u{'g߄ k3gۡ϶C}7?cb2*W;v(X)߀)?Pgۡ>?ssW?.϶Cݟmz+>'<?#?_߉gۡ϶C}_Sg/_ o/7?u{?bB5k/77vP ?4K?~~ޟm?=cggo߃_&}xlg1y7?:/vP-wO_ 0~-UFV?u}q}(X'W )ޟm?]??=~%AW;l;vc|O / ;l{&O-~/;ޟm?}? 6bB5k/77>Ï}? s}/?gۻ6s}??  js7]-C? p$7?gaܟm/{mll;4atF{m0ζ;vDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێ0o϶=Ͷvқm?;~=϶@T1wmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1voO:OowvP0h9o[K?? ϶CݟmGOğ ~9~ xl;?? !2R{ǿ߄߆gۡ϶C}OXdY%[Wÿ9ޟm>[~ ~<~"~*~~*Mſ xl;w ]///ï?_϶w]E\?*o߉igۡ϶C}h!c'/__$?um3jſm{zSζ:mxl;G῍?~Be[? ϶CݟmHgߌogۡ϶C}xDT `)sů8ePgۡ;'__?~ Efv?u}v gq῏?'z/l{fcggo߃_&xkeG???5fGl;̛zOmf_zmlk[z}7[P϶Cݟm(GOO_ +^o7vP?8~tL|w l;v ._ޟm?|_ooPgۡ+~c_Cǿ϶Cݟmh!c'/__$?uvtWߎ~|'ޟm?}O-6/ſ##l;v?$DY ǯ߀ߌߎgۡ϶C}/8//ߊ(y[Mmxl;ďOOƟ__~59u\'g߄ Ygۡ϶C}w? Rb2*W{Y~c)F_'xl;w?2\"O_Pgۡކ)><3< +Ưÿ߂]g>??~6r_ǿ1xl;$ ǯ߀ߌߎgۻ ?=g/3ÿ_%ޟm>~,~~2 ,-{϶w HgߌޟmysT/ͪ[xf޿p 3}~b?[wx㟭z{[4GǷ^^ >bW }+>'<?/oC_GǷ)9^%^5-sv<3< +;|nGǷ)9^%^5-I{xxxxxx?VxxxxxxOO#| ^^ XC#| ^^ .q ><3< +;|n-G ^^ >XG#|O / o[O?>gxxxxxxE~+>§ O/ov~ >§ O/oFS|'xgxxWx7xw&c)><3< +;|.?=[[1>gx{2< +;|@o ^^ >gxxxxxxAA>Ƨ O/o𹃇Lc|O / o;d!>Ƨ O/o9?PS|xxxxx/;8 ^^ ppS|'xgxxWx7xw?s S|'xgxxWx_Fc|O / o#zo{/}|eG_UZwV w|ߎgxxWx7xwx؝}oGǷ^^ v}_GǷ)9^%^5-aw>}|Oy|;^^ vXE#|/o;~>'<)9^%^5-aw>>'<)9^%^5-aw>|Oygxxxxxx?3>§ O/oנ?"S|'xgxxWx7xwx؝c)><3< +;< ^^ vDc|O / oA>Ƨ O/o;ǁC߆)><3< +;<y1>gxxxxxx{Jo?1>gxxxxx:<q)><3< +;<Lc|O / oG3Ƨ wMxxxxx??1>gxxxxxx??1>gxxxxxx/Jm ^^Al?1>gxxxxxoO3< +;<~% >oS|Oygxxxxxx?3§ O/o;S|'xgxxWx7xwx؝c#)><3< +;< ^^ v|O)9^%^5-aw> S|'xgxxWx7xwx؝cзc|O / oAl?1>gxxxxxx??1>gxxxxxxyߣ|O)9^%^5-awS|'xgxxWx7xwxxa3gxxxx{]awaw>m>Ƨ O/o߁]yTmwޝwf[jߝ?rpw=^#| / o_1vtoS'xgxxWx7xwx؝c >'xgxxWx7xwx`>' O/o;Z|'xgxxWx7xwx؝c ><3< +;<G ^^ GD#|O / oAl?>gxxxxxx?63菘 ^^ v8p1>gxxxxxx?6}>Ƨ O/o;S|'xgxxWx7xwx؝ S|'xgxxWx7xwx؝=: ^^ v}?1>gxxxxxxq()><3< +;<q)><3< +;<q8)><3< +;< ^^ ;;6S|'xgxxWx7xî^;cwΓˎHmwkw}vt'<?/o;>'<O / oAK#|/o;*|ߎxxxxx??>O / oA?>O / oAO#| ^^ vXC#| ^^ .q ><3< +;<G ^^ vXG#|O / oA?>gxxxxxx3菍>Ƨ O/o;&S|'xgxxWx7xwx؝#?1>gxxxxxx?6|O)9^%^5-aw>C߆)><3< +;< ^^ v8 ^^ v}?1>gxxxxxxyߣC|O)9^%^5-AJc|O / oAFc|O / oANc|O / oAl?1>gxxxxx< ^^ ;+﷗/[ܝ_vE{۝h w/X?ܝ} / o_1vtoS'xgxxWx7xwx؝c >'xgxxWx7xwx`>' O/o;Z|'xgxxWx7xwx؝c ><3< +;<G ^^ GD#|O / oAl?>gxxxxxx?63菘 ^^ v8p1>gxxxxxx?6}>Ƨ O/o;S|'xgxxWx7xwx؝ S|'xgxxWx7xwx؝=: ^^ v}?1>gxxxxxxq()><3< +;<q)><3< +;<q8)><3< +;< ^^ ;;6S|'xgxxWx7xî^;?{qw~a}v}ïE6 w}vt'<?/o;>'<O / oAK#|/o;*|ߎxxxxx??>O / oA?>O / oAO#| ^^ vXC#| ^^ .q ><3< +;<G ^^ vXG#|O / oA?>gxxxxxx3菍>Ƨ O/o;&S|'xgxxWx7xwx؝#?1>gxxxxxx?6|O)9^%^5-aw>C߆)><3< +;< ^^ v8 ^^ v}?1>gxxxxxxyߣC|O)9^%^5-AJc|O / oAFc|O / oANc|O / oAl?1>gxxxxx< ^^ ;+﷗OZܝtܴrv/MOy|;~:9^%^5-aw+|ߎgxxWx7xwx؝}J|ߎxxxxx??>xgxxWx7xwx؝c >oSO / oA?>O / ol8G ^^ vXK#|O / oA?>gxxxxxx?3 >§ O/o;FS|'xgxxWx7xwx؝c)><3< +;<3Ƨ O/o;o ^^ vBc|O / oADc|O / oG3Ƨ O/o ??1>gxxxxxx??1>gxxxxxx??1>gxxxxxx?3oO3< +;<~з#| / oA?>xgxxWx7xwx؝c_|ߎxxxxx?Vv<3< +;< >'xgxxWx7xwx؝c5 >'xgxxWx7xwx؝c|O/o;|O/op6|O)9^%^5-aw>菵>' O/o;:|'xgxxWx7xwx؝c=)><3< +;<5菈G ^^ v@#|O / oAl?1>gxxxxxx?63<3< +;<qзc|O / oAl6|O)9^%^5-aw>->Ƨ O/o;A>Ƨ O/o;{t0)><3< +;<Bc|O / o/ PS|'xgxxWx7xwx؝0S|'xgxxWx7xwx؝pS|'xgxxWx7xwx؝c+)><3< +waw>m>Ƨ O/o߁]X/W͝Ÿԏ˗^ng,lΝ%v}/Κ;}Թgl{_znӍssXy n.s/=7|svν%UwyI=; ?~[7p; [,wkۻ/_nى_Zφ/߭KN8| n]<]w|,7rƅ}w<7-O|p /ﶍs=Zrr鱚bl^8\G.[|<=\ ?qwsO]Ecn'q5߮۲ų9bduwX/ >ޥe|,w,H8qOօA /}Nrͻogmztρ' ݷn};dӍnoݸvn}nv_nZ~uoOZwpk_ք ÛwߺCwߎߺ~|xn\|x6]s7 yce =kN2b /j/5 v3N}'was_s}>烿vV`^V|09|>;`{S};_r?oټ;s;lZh>٬cZYyȆݹl! .l~ {:p} Gs5?\ClЦׇcݙ[sh- cavk"]~wf|} }x~s ǹx0stq@-izox!tG:o-{u㜸n? .\sC5"Zk8kegPys5dU,5ϵ\C֥-'5c¹kńc˯ss-9t\CkRzw!|/ԯX;+ѹl_=L^s pok+c_\hx!?.ks ;_{U݅'vް?>pOB}hoU]+WCwk5̕ñ9p9r\C\l2k!5$ñ9pf[::vgޱl׌s,toY;wНY%Нwͺ\Y\vOWc{?e缶^+o?\ypoOuxϭ>~oxxlxsh}[}lԮ?v!(`CwʦTw ;ơbq{K9߱a~p0{=/>Z1u>f1h{V6no֠uO2u}Qf<8w)a|EơN T%s壌O2uJ'8H]5h);X{^4!9/+C0O(0cl01Lٸe?u9h +m\7*G`|q]0OE(0c00OVS>$Pǀy4YWnGu| 0~Mu7rS?+-"6+<8<|Ia<bDfg#{j)a|Ea]6Mg11OQ>$.D=/՛W=>Wq<۳~Y(2,2㴱@5 7t ;daҥ"Yy!Vf~zqcwFc|V?ZZ SK/բR z?K;zހ.eMSIz3a5VMY{Bj5NQ{O]Ѓ8KM]YԻe\VMj}`\U~ϵگƻb{Zl09+bmPІM--Iؚg+4;qĝ9bB1ѧ~`cM9ؘC>s1?l(sarјQ6R6Suyf7ϯY!>*Eppی8X\|I9ؘ<<77w)S P P>|8D*T{.2wfn`gqĎ&˲g{L*qRgی mAw}BKMņVbGMՆ.\@7`Æ][ f*m6tIo-tot{Q~j;Rm;(uO[ޯRiCw=lQeCQ[n딺 gkK붔*?+~Vǟ1Ǜ=4qǛ\9ǟkO8vǟlQ\u1 wjaּm^8I58,[ګ-절}O kvP7$oyw#}$&A(v^vlGTF\Gm/{8p笀vR~ɸq7^ʧ1^x%xp.Ì)x6x 5GZW`2(wYޔGi!NDd J h`b  c $A? ?3"`?"kMO\/MhGMZ}@=?MO\/MhP(P< Mx %u/W&ٱspAsq nz1GtMԫW j\MQ5UtܓtQEՐƍUo=N}"}յdnns9xEKnG;nss9AssK~ܥVgm !mlX6{,mn/ܢ۝>ۖl{{Ջuin%?ۺu~~n- g;77ۺukx+w~;o6sg̝:wlzV5 p%-ue3zۗZ|ٿ[?߯;눅_8q~/}0;]voهuHooyv>n[on΋__<;\q}{o+4<ߕ sc~,kKÿʟ]vq9Ƿ.|w6{lxyj V|wq\ڿ` ^Xg zn3o3C??6|O_ſ_߈^6} `>'gߌ$/_7+}C~~4~~2~"Uƿ{|+~^ß%~!V}C=~O(c/_Q ?/]5u ???? |\%+[A׮|Oy|3~*w]?.~Z"ek{ .G_?)kkߚ???"~b<-KWoWٞ\G'/_ e?+}C#~o%~!""{G?? F/~uC_nŏďOŸ??'~ y G|G뇾S|'xgxxWx !~s/ DKo?&7kn? \EW7\G?45*WMnp}g1 3o߇_%G|վCwߡ ~<tl0osw6~lݽW_w>l{GcwP߄gۡ϶C}7G_?)kl;v??~:~6j{O~ޟm?߄_3%;vP~ag/__8~9mxl;Է? t7?Wol;v7G'Oß_<~#| ޟm?|Oy|3~*Ï$$9? ikUl{>\'O_~)Jl{vf8Mxl;ԇ?~ l%[¿϶Cݟm`>'gߌ$/_7vP ? ???? *M?_¿ =ޟm?{?&B{_gۡ϶C}{QCO_.϶Cݟmz~(~$~,~4;KW?·vPoG7_s[l;v~"TL?wl;v0(ss/ÿ__ߌgۡ϶C}A#Sg/ߊU5xl;wǏO? >R+/l{ٞ\G'/_ e?vP7gqrOl{Y~O(cgg߈EPgۡ~(~$~,~4;KW?·vPo ^^_omg{q}~"TL??l;v-__ :~5~-~3ޟmo>ۛ3GOŸ#ƿ_ ϶]~8~ ~D y[_϶}OO_/ ?l{G%g*lWpeێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rvDn;"ێmG#rh8l{Gv8NzW-}Jvx϶wԷcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&ێmcr1vLn;&gjlfW-mlw8Qޫ߄gۡ϶C}7G_?)kl;v??~:~6j{O~ޟm?߄_3%;vP~ag/__8~9mxl;Է? t7?Wol;v7G'Oß_<~#| ޟm?|Oy|3~*Ï$$9? ikUl{>\'O_~)Jl{/w̶᪥ٰw6 g;0m&?uC??6|O_ſ_߈gۡ϶C}0~Woߋ{/l;v&b/϶Cݟm?!JB=o?ůPgۡ=~O(c/_Q ?gۡ϶C ???? |\%+[l;v7#|S/_9[xl;w??*~&Ru;kOxl;w?d9k_ǯƯoPgۡ ~ )oߏ *}F?u;'O_~)J xlO߄_2]l;vp__8~9mx, '~P3Woߍ "oOvP???? |\%+[l;v7c|O / o?į÷볽>??*~&Ruſ xl;w{S/?_϶]~w#' OO_ï߄gۮ ???"~b<-KWg`>'gߌޟmysl gܦ_m~lɦ/l;ycYprOy|3~*9^%^5-sˆv7#|S / o[>|Oy|3^^ >XA#|/oJ|ߌxxxxxϭ?Vxxxxxx9?VxxxxxxFF#| ^^ ؝G<3< +;<\ c|'xgxxWx7xwc ><3< +;|nOcO|'xgxxWx7xwZc-)><3< +;|.?]>gxxxxx;]XG?>gxxxxxxϭ?3gxxxxxxOk>Ƨ Op_WxxxxM=3gxxxxxsx~~>Ƨ O/oOc|O / o;`>Ƨ O/o9ߓ@S|xxxxx/98 ^^ m|O)9^%^5-K6lF|O)9^%^N~6d|Fc#)><3< +ŷK6 ;]ﺸ;-+lZrW+Z9ܝncOy|3~*9^%^5-awˆ|ߌgxxWx7xwx؝}r|ߌxxxxx?Vf<3< +;<G7)9^%^5-aw>U>'<)9^%^5-aw>>'<)9^%^5-aw>|Oygxxxxxx??>gxxxxxx?3u>§ O/o;zS|'xgxxWx7xwx؝c/S|'xgxxWx7xwx؝#?1>gxxxxxx?F|O)9^%^5-aw>}S|'xgxxWx7xwt>Ƨ O/ovV??1>gxxxxxxyߣ|O)9^%^5-awS|'xgxxWx7xw!:N/o;A>Ƨ O/o;m|O)9^%^5-K6r1>gxxxx;o||O)9^%^5-~{G[v燬^ջڝ|z;u#|S / o]6 fT菕>'<O / oA?>O / oA?>O / oAF#| ^^ v؝G<3< +;<\ c|'xgxxWx7xwx؝c ><3< +;<' ><3< +;<G ^^ GD#|O / oA?>gxxxxxx?3<3< +;<7c|O / oA33Ƨ O/o;{t)><3< +;|wHc|O / oADc|O / oAܖ ^^ dڈ)><3< +Al?1>gxxxxx<vyx}w~ݗlڝ?>ܝ_fT'<?/o;>'<O / oA?>xgxxWx7xwx؝c% >oSO / ol؃G ^^ vXC#|O / oAI#|O / oA?>gxxxxxx3>Ƨ O/o;^>Ƨ O/o;GLc|O / oA=3Ƨ O/o;Ǿ>Ƨ O/o;~>Ƨ O/o;{?)><3< +;<@c|O / o @S|'xgxxWx7xwx؝ S|'xgxxWx7xwx؝>Ƨ O/o;S|'xgxxWx7xo||O)9^%^5-~{Gw矾ewY)YyZw'OX3ܝ}S / o]6 fT菕>'<O / oA?>O / oA?>O / oAF#| ^^ v؝G<3< +;<\ c|'xgxxWx7xwx؝c ><3< +;<' ><3< +;<G ^^ GD#|O / oA?>gxxxxxx?3<3< +;<7c|O / oA33Ƨ O/o;{t)><3< +;<2|O)9^%^5-aw>菃|O)9^%^5-aw>3gxxxxx<v./ewK6=gvYuww}fT'<?/o;>'<O / oA?>xgxxWx7xwx؝c% >oSO / ol؃G ^^ vXC#|O / oAI#|O / oA?>gxxxxxx3>Ƨ O/o;^>Ƨ O/o;GLc|O / oA=3Ƨ O/o;Ǿ>Ƨ O/o;~>Ƨ O/o;{?)><3< +;<@c|O / o @S|'xgxxWx7xwx؝ S|'xgxxWx7xwx؝>Ƨ O/o;S|'xgxxWx7xo||O)9^%^5-~{G3oٝuK6uڝu^w]7ܝ}S / o]6 fT菕>'<O / oA?>O / oA?>O / oAF#| ^^ v؝G<3< +;<\ c|'xgxxWx7xwx؝c ><3< +;<' ><3< +;<G ^^ GD#|O / oA?>gxxxxxx?3<3< +;<7c|O / oA33Ƨ O/o;{t)><3< +;<2|O)9^%^5-aw>菃|O)9^%^5-aw>3gxxxxx<v/Ώew^dS׮v/{ wok;7^^ v}_l>xxxxxy.?>xgxxWx7xwx؝c >oS'xgxxWx7xwx`>' O/o;|'xgxxWx7xwx؝cO|'xgxxWx7xwx؝c-)><3< +;<5菈G ^^ vXG#|O / oA?1>gxxxxxx??1>gxxxxxx?bS|'xgxxWx7xwx؝co ^^ vg1>gxxxxxx??1>gxxxxxx??1>gxxxxxxyߣ|O)9^%^5-awS|'xgxxWx7xwxxe3gxxxxxx?63oO3< +;xgxxWx7xwx؝c >oS'xgxxWx7xwx`>' O/o;|'xgxxWx7xwx؝cO|'xgxxWx7xwx؝c-)><3< +;<5菈G ^^ vXG#|O / oA?1>gxxxxxx??1>gxxxxxx?bS|'xgxxWx7xwx؝co ^^ vg1>gxxxxxx??1>gxxxxxx??1>gxxxxxxyߣ|O)9^%^5-awS|'xgxxWx7xwxxe3gxxxxxx?63iK>ۺunsޒm/~}Kn3N;ys?ϊ~n_wi?km}ˏuYᛳa/8-{hᣟ={|7|\~Y-^ /ߵezmYdѝynk< Y~[BчX1tru׭_ozo>׭\K>^ǍNoa{vj_;/KC~ů'_|=֏u ?g{ `۟[?Ml_m-Yse؅=l}r^3}OW [<QߓC/?݆5.>}݇{?g2x<w|.^>s9^Ⴛo{G7l6qw'nmi`J4`RL R(5i5[c,A*DR` K!z(bK4A{Pl}7o6oF/ <2Ly'E$s01?|eo0֥g(ٟ01(/1>8L,bI_a eea-)?a*)?9V~g}|:UxVϰĪ2h3xaԋ?3y롏s麁xs^fL7Iu,_剡a*RgnG{ϬFW9_fWOP9y'vg9wMK*?Cv 5ih\JkVu>kkhuqkJFTo#U76zJ%ޝv3꽯.hw13Q-hV76P^⶯n;L%7hO{2=-gL,;gU E1&&ĈxCT$XT%ՕVg9r-s.`c~$A9ؘR6nr1_P6旲Tr1a#`cm3`c'˟I~<{v(?'~ۡlSM(JPޕ|oI|()'RPϰ} NBoXS6G{B(/1AauUi_>=7펠i2퉠 #m~0AwQ.juJFZLwgݏ_Sf}tJ-?3]tS/jtsY3tnFtitlX[{*_~Ow?ƗxR~z?i< Xѫ/gW/3:e=}WmeDi˟R,Lgś5^qB>Se? '[mQvqyh%UߕiDU9*(!t{ #e׎*~Bpě,xL U..͔x 㭌R*k**B*phj@j 4 Table Grid7:V04 @4 "Footer  p#.)@. " Page NumberSSuv,- mBPQ 9:GHdx`a    $%  x!"M#N#d#e#$N&u'())))g0i39::::";;;;;;<[=/>>Y?@@ABCCUD EE2F2G0HIIJKLLLLMIMMMMM+N,N-N]N^NhNmNqNrNNNNNNNNNNNOOO/O>OOOPOhOwOOOOOOOO P PPPP>PFPNPOPZP]P`PaPtPPPPPPPPPPPPPPPPPPPPPPPPPPPQQQ Q$Q%Q&Q'Q6Q\QQQQQQRRR&R.R6RARBRPRURZR`RfRgRqRwR}RRRRRRRRRRRRR SSSSSSSSHSISJSjSlSmSoSpSrSsSuSvSSSSSSSSS000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0  0  0  0  0  0 0 0 0 0 0 0 0 0000000000000000 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00 0 0 0 0 0 0 0 0 0 0000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000 0 0 0 0 0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 00000000000000000I00rI00I00rI00I00rI00I00rI00I00rI00I00@0@0I00I00I0`PaPtPPPPPPPPPPPPPPPPQQ$Q%QARBRPRURZR`RfRgRqRwR}RRRRRRRRRRSK00 AI00K00 DK00K00K00K00K00 K00 K00 K00K00K00K00K00I00K00@0? K00 @0 K0 0 @0 K00 %I0 0 K004 %K00 K00 I0 0 I00 I0 0 I00I00I00I00TI00@0I00K00K00I00I00@0  00L %%%(` $['>*,/,1'4@7AqDGLR&Q̗.1235678:;<=>@ABCDFGLQ\g$0/J#ɒLMΔؔޔ8\ yЖ̗/49?EMNOPRSTUVWXYZ[]^_`abcdefh˗0S8S:SJSfShSSX:: !(!!  /X"$=gc\Q3 "$|2p(' @ 0(  B S  ?S'DJJfILJ KܜKKDIS      !"#$%&  1:ASZbkk imrrl8l8>S  !"#$%&9 *urn:schemas-microsoft-com:office:smarttagsState=$*urn:schemas-microsoft-com:office:smarttags PlaceName='*urn:schemas-microsoft-com:office:smarttags PlaceTypeB *urn:schemas-microsoft-com:office:smarttagscountry-regionh"*urn:schemas-microsoft-com:office:smarttagsCity0http://www.5iamas-microsoft-com:office:smarttagsV!*urn:schemas-microsoft-com:office:smarttagsplacehttp://www.5iantlavalamp.com/ '''$'"! '''$'"! '''$'"! "! "! $''!$! !BGYcerwQ`')24AV d K X Z d i r x  ( * 6 8 A y  NO`aeg}KVHnoa -Xbdmoy~bm%,7`k)1;=FHQS[:DZb  p { !!'!4!=!M!N!X!")"6"A"g"r"""$$$$$$%%%"%%%'%(%3%5%K%L%%%%%%%%%%%M&(/))****v*x*}**********+++ +*+,+a+c+d+g+++++++++++%,&,p/q/f000i33333333384b6l6a8l8:!;";;;;;;;;;;;;;;; < <<<Z<\<g<h<m<n<<<<<<<<<9=:=>=?=@=A=I=J=O=P=S=T=X=[=}=~==>>>@>B>>>>>>>>>??/@0@F@H@@@@@A A AAAAABBBB}C~CCCCCZD[D\D^DdDeDfDhDmDnDoDpDrDsDuD{D|DDDDDDDDDDDDE E%G'G8G:GDGFGMGNGSGUGH H%H&H.H0HIIJJJJJJ|K}KKKKKLLLLLLLLLLLLmMnMMMNN*N.N5N6NONPN\N^NqNrN{N~NNNNNNNNNNNNNNNNNNNNNNNOO OOO O"O%O(O+O=O>ONOPOXO[O\O_O`OcOvOwOOOOOOOOOOOOOOP4P7PEPFPMPOPYPZP\P]P_PaPiPjPlPnPoPrPsPtPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPQQQQ Q#Q'QQQQQRR%R&R-R.R5R6R@RBRORPRTRURYRZR\R`RbRgRpRqRtRwRzR}RRRRRRRRRRRRRRRRRRRRRRRRR SSS?SHSjSjSlSlSmSmSoSpSrSsSuSvSSSSoyHP Hc@Lgkuz!!$M&&(+((((/)i)n))))f0i384:!;";;;;;<<Z=[=.>/>>>X?Y?@@@AAABBCCCCTDUDwD EEE1F2F1G2G/H0HIIIIJJKKLLLLMMHMIMMMMMMM*N.N\N^NgNhNlNmNpNrNNNNNNNNNNNNNNNNNOOOO.O/O=O>ONOPOgOhOvOwOOOOOOOOOOOP PPP=P>PEPFPMPOPYPZP\P]P_PaPsPtPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPQQQQ Q#Q'Q5Q6Q[Q\QQQQQQQRR%R&R-R.R5R6R@RBRORPRTRURYRZR_R`ReRgRpRqRvRwR|R}RRRRRRRRRRRRRRRRRRR SSS?SGSjSjSlSlSmSmSoSpSrSsSuSvSSSS33333333333CO 8:GaN,t+ ?  $N#e##'$W$%%V%%&))*** +,,::;;;;\<<:=[=>/>>>.?Y??@@@AABBxCC6DTDD E G2GH0HIIJJ}KKLLnMM^NNNO/OOO P PP>PaPPPP6QRRRSjSjSlSlSmSmSoSpSrSsSuSvSSSSa8l8jSjSlSlSmSmSoSpSrSsSuSvSSSS /ο>hh^h`6o(. /-JxOV k"' Q$pJb^zD" #-$ (t+I- S.n0^0F1%2_56=j=p?`BSD(`FbH~Ir3JUJ,LR T1XX6pY[/[ _$ab,cTcd e kk@ k*kUk#l!m tVmwxd`|2}23}cd}u}+ufpS"k<TrfLj2!m 2~N:S:(X aIN9-{Y<!V(=n%h"4~~cS&e-Ze)u/{#Z1C} e"@_lE"@=n;**o u|_Xv#M+N^NhNmNqNrNNNNNNNNNNOOO/O>OOOPOhOwOOOOOOOO PPP>PFPNPOPZP]P`PaPPPPPPPPPPPPPPPPPPPPPPPQQQ Q$Q%QQRR&R.R6RARBRPRURZR`RfRgRqRwR}RRRRRRRRRRS@a8a8(a8a8|BD"E"FKS@@ @@@@ @@N@@@T@@@ @UnknownGz Times New Roman5Symbol3& z ArialiCroTimesNewRomanTimes New Roman?5 z Courier NewG  MS Mincho-3 fg"1'+Ɩ+Rs F*s F*!4d@S@S2QHX ?uf2~RITUXIMAB, BUT NOT A CHANGE FROM IMVP (IFOSFAMIDE, ETOPOSIDE, METHOTREXATE) TO ICE (IFOSFAMIDE, CARBOPLATINUM, ETOPOSIDE) IMPR Dr. Igor Auer igor.aurer